Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jandeleit

Showing results (71-80 of 190) with videos related to

Pageof 19
Sort By:
Journal of Neurology|May 22, 2014
Auditory neuropathy in individuals with Type 1 diabetesGary Rance, Donella Chisari, Fleur O'Hare, et al.
Sensors (Basel, Switzerland)|September 19, 2025
Rapid, Precise, and Clinically Relevant Quantification of Urinary Albumin and Creatinine Using a NanoDrop UV/Vis SpectrophotometerKeith E Dias, Karly C Sourris, Jay C Jha, et al.
Kidney & Blood Pressure Research|February 6, 1999
Effects of neutral endopeptidase inhibition in the rat remnant kidney modelK Jandeleit-Dahm, L M Burrell, M Kanazawa, et al.
Nephron|January 1, 1990
Increased activity of the autonomic nervous system and increased sensitivity to angiotensin II infusion after therapy with recombinant human erythropoietinK Jandeleit, B Heintz, E Gross-Heitfeld, et al.
Analytical Methods : Advancing Methods and Applications|November 12, 2024
Simultaneous determination of glucose and albumin in human urine using attenuated total reflection Fourier-transform infrared spectroscopyKeith Dias, Pukkaramai Koohachaisakul, Thanaree Hainak, et al.
Diabetologia|April 7, 2007
Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal diseaseM Lassila, K Fukami, K Jandeleit-Dahm, et al.
Kidney International. Supplement|July 21, 1999
Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathyK Jandeleit-Dahm, Z Cao, A J Cox, et al.
Therapeutic Advances in Endocrinology and Metabolism|March 31, 2022
Examining the factors contributing to the association between non-albuminuric CKD and a low rate of kidney function decline in diabetesOyunchimeg Buyadaa, Agus Salim, Jedidiah I Morton, et al.
Trends in Endocrinology and Metabolism: TEM|April 1, 2019
Reactive Oxygen Comes of Age: Mechanism-Based Therapy of Diabetic End-Organ DamageMahmoud H Elbatreek, Mayra P Pachado, Antonio Cuadrado, et al.
Journal of Hypertension|February 18, 2005
Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetesKarin A M Jandeleit-Dahm, Christos Tikellis, Christopher M Reid, et al.
Pageof 19

Showing results (71-80 of 190) with videos related to

Sort By:
Pageof 19
Journal of Neurology|May 22, 2014
Auditory neuropathy in individuals with Type 1 diabetesGary Rance, Donella Chisari, Fleur O'Hare, et al.
Sensors (Basel, Switzerland)|September 19, 2025
Rapid, Precise, and Clinically Relevant Quantification of Urinary Albumin and Creatinine Using a NanoDrop UV/Vis SpectrophotometerKeith E Dias, Karly C Sourris, Jay C Jha, et al.
Kidney & Blood Pressure Research|February 6, 1999
Effects of neutral endopeptidase inhibition in the rat remnant kidney modelK Jandeleit-Dahm, L M Burrell, M Kanazawa, et al.
Nephron|January 1, 1990
Increased activity of the autonomic nervous system and increased sensitivity to angiotensin II infusion after therapy with recombinant human erythropoietinK Jandeleit, B Heintz, E Gross-Heitfeld, et al.
Analytical Methods : Advancing Methods and Applications|November 12, 2024
Simultaneous determination of glucose and albumin in human urine using attenuated total reflection Fourier-transform infrared spectroscopyKeith Dias, Pukkaramai Koohachaisakul, Thanaree Hainak, et al.
Diabetologia|April 7, 2007
Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal diseaseM Lassila, K Fukami, K Jandeleit-Dahm, et al.
Kidney International. Supplement|July 21, 1999
Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathyK Jandeleit-Dahm, Z Cao, A J Cox, et al.
Therapeutic Advances in Endocrinology and Metabolism|March 31, 2022
Examining the factors contributing to the association between non-albuminuric CKD and a low rate of kidney function decline in diabetesOyunchimeg Buyadaa, Agus Salim, Jedidiah I Morton, et al.
Trends in Endocrinology and Metabolism: TEM|April 1, 2019
Reactive Oxygen Comes of Age: Mechanism-Based Therapy of Diabetic End-Organ DamageMahmoud H Elbatreek, Mayra P Pachado, Antonio Cuadrado, et al.
Journal of Hypertension|February 18, 2005
Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetesKarin A M Jandeleit-Dahm, Christos Tikellis, Christopher M Reid, et al.
Pageof 19